Published February 10, 2025 | Version v1

Whole Exome Sequencing of Neuroendocrine Neoplasms of Ovarian Origin

Description

Primary neuroendocrine tumors of the ovary are a heterogenous family of neoplasms that have a wide range of characteristics and prognosis. Relatively little research has been done on the topic of genetic commonalities in this class. The authors sampled four cases of neuroendocrine ovarian tumors, two well differentiated neuroendocrine tumors and two non-small cell neuroendocrine tumors. Deoxyribonucleic acid (DNA) libraries were prepared, and 14 genes of interest were found in one or more of the cases. Six genes of interest were identified in all four cases: Cancer antigen 125 (CA125), Mucin 6 (Muc6), tumor protein 53 (TP53), ataxia telangiectasia mutated (ATM), lysine methyltransferase 2D (KMT2D), and neurotrophic tyrosine receptor kinase 1 (NTRK1).

Files

Files (985.7 kB)

Name Size
md5:e44d7d032f1800807835593f1556fa77
985.7 kB Download

Additional details

Related works

Is published in
Journal: 3066-3202 (ISSN)

Dates

Accepted
2025-02-07

References

  • 1. Szybowska M, Mete O, Weber E, Silver J, Kim RH. Neuroendocrine Neoplasms Associated with Germline Pathogenic Variants in the Homologous Recombination Pathway. Endocr Pathol. 2019;30(3):237-245. doi:10.1007/s12022-019-9569-4
  • 2. Modlin IM, Bodei L, Kidd M. Neuroendocrine tumor biomarkers: From monoanalytes to transcripts and algorithms. Best Pract Res Clin Endocrinol Metab. 2016;30(1):59-77. doi:10.1016/j.beem.2016.01.002
  • 3. Opalińska M, Sowa-Staszczak A, Olearska H, et al. Clinical Approach to Neuroendocrine Neoplasm Associated With Ovarian Teratoma. Front Endocrinol (Lausanne). 2021;12:770266. Published 2021 Nov 30. doi:10.3389/fendo.2021.770266
  • 4. Veras E, Deavers MT, Silva EG, Malpica A. Ovarian nonsmall cell neuroendocrine carcinoma: a clinicopathologic and immunohistochemical study of 11 cases. Am J Surg Pathol. 2007;31(5):774-782. doi:10.1097/01.pas.0000213422.53750.d1
  • 5. Zhu Y, Meng F, Fang H, et al. Clinicopathologic characteristics and survival outcomes in neuroendocrine carcinoma of the ovary. Int J Gynecol Cancer. 2020;30(2):207-212. doi:10.1136/ijgc-2019-000746
  • 6. Pang L, Guo Z. Primary neuroendocrine tumors of the ovary: Management and outcomes. Cancer Med. 2021;10(23):8558-8569. doi:10.1002/cam4.4368
  • 7. Mulders MCF, de Lussanet de la Sablonière QG, van Velthuysen MLF, et al. Unfavorable biological behavior and treatment response of neuroendocrine ovarian metastases of midgut neuroendocrine tumors. Endocr Relat Cancer. 2023;30(8):e230035. doi:10.1530/ERC-23-0035
  • 8. Leclerc J, Tihy M, Genestie C, et al. Updated Morphological and Immunohistochemical Profile of Neuroendocrine Tumors Developing in Ovarian Teratomas: A Large Series of a Rare and Heterogeneous Disease. Int J Surg Pathol. 2024. doi:10.1177/10668969241271923
  • 9. Burkeen G, Chauhan A, Agrawal R, et al. Gynecologic large cell neuroendocrine carcinoma: A review. Rare Tumors. 2020;12:2036361320968401. doi:10.1177/2036361320968401
  • 10. Flores Legarreta A, Saab R, Gonzales NR, et al. Neuroendocrine neoplasms of the ovary: a review of 63 cases. Int J Gynecol Cancer. 2024;34(4):566-573. doi:10.1136/ijgc-2023-005063
  • 11. Bellizzi AM. Immunohistochemistry in the diagnosis and classification of neuroendocrine neoplasms: what can brown do for you?. Hum Pathol. 2020;96:8-33. doi:10.1016/j.humpath.2019.12.002
  • 12. Rindi G, Mete O, Uccella S, et al. Overview of the 2022 WHO Classification of Neuroendocrine Neoplasms. Endocr Pathol. 2022;33(1):115-154. doi:10.1007/s12022-022-09708-2